Mabxience

SME

Mabxience

Description

The entity profile has not yet been completed.

This entity is yours?
Sign in to update information and position your organization seamlessly within the European bioproduction Value Chain. Benefit from the geolocated map to showcase your expertise, projects, and initiatives. Boost your visibility and make meaningful connections within the ecosystem. Sign in

Mabxience

Address

Leon, Castilla y Leon, Spain

Contact

Online form

Description

The entity profile has not yet been completed.

This entity is yours?
Sign in to update information and position your organization seamlessly within the European bioproduction Value Chain. Benefit from the geolocated map to showcase your expertise, projects, and initiatives. Boost your visibility and make meaningful connections within the ecosystem.

Matchmaking

Connect with Mabxience

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways

Mabxience last news

22/01/2024

The Evolution of Biopharmaceutical Manufacturing

The past decade has seen remarkable advancements in biopharmaceutical manufacturing, transforming how we develop and produce vital medications. This evolution not only represents a leap in scientific innovation but also highlights the importance of reliable and efficient manufacturing partners in bringing life-saving treatments to market. The Rise of Biopharmaceuticals: Biopharmaceuticals have revolutionized healthcare, offering targeted [...] La entrada The Evolution of Biopharmaceutical Manufacturing se publicó primero en mAbxience .

15/01/2024

Celebrating Emmanuelle Lepine's Legacy of Excellence at mAbxience

As we navigate through continuous change and growth at mAbxience, we are both reflective and grateful for the exceptional leaders who have shaped our journey. We mark a significant transition as Emmanuelle Lepine, our esteemed CEO, stepped down to pursue new adventures. Over her seven-year tenure, Emmanuelle's impact has been profound. With over two decades [...] La entrada Celebrating Emmanuelle Lepine's Legacy of Excellence at mAbxience se publicó primero en mAbxience .

20/12/2023

mAbxience Announces Licensing Agreement with Intas Pharmaceuticals Ltd. for Etanercept Biosimilar Targeting Autoimmune Diseases in more than 150 Countries, including Europe and the United States of America

Intas to gain commercialization rights for Etanercept biosimilar in more than 150 countries worldwide. mAbxience to develop, manufacture, and supply the Etanercept biosimilar. This collaboration marks a significant step forward in providing enhanced global access to advanced treatments for autoimmune diseases. Madrid, December 20th, 2023 — mAbxience (a Fresenius Kabi majority-owned group with partial ownership [...] La entrada mAbxience Announces Licensing Agreement with Intas Pharmaceuticals Ltd. for Etanercept Biosimilar Targeting Autoimmune Diseases in more than 150 Countries, including Europe and the United States of America se publicó primero en mAbxience .